:: Class Utilisation Summary 2016
See LEGEND for key to shading and symbols.
:: Subject Area - OPTM Term - Semester 1
Data is correct as at Mon Oct 10 19:05:21 AEDT 2016
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
OPTM0001 | Research Thesis Optometry F/T | ||||||
THE | 0001 | 1373 | Enr | Open | 27/60 | 45% | |
OPTM0002 | Research Thesis Optometry P/T | ||||||
THE | 0001 | 1374 | Enr | Open | 9/60 | 15% | |
OPTM2190 | Intro Clinical Optometry | ||||||
LAB | GP1 | 7531 | Enr | Full | 22/22 | 100% | Wed 16-18 (w2,4, Myers 2009); Wed 16-18 (w3,5-11, Myers 2009); Wed 16-18 (w12-13, Myers 2009); Fri 12-14 (w2-4,5-12, Myers 3016) |
LAB | GP2 | 7532 | Enr | Stop | 22/22 | 100% | Tue 14-16 (w2-4,5-12, Myers 3016); Tue 16-18 (w2,4, Myers 2009); Tue 16-18 (w3,5-11, Myers 2009); Tue 16-18 (w12-13, Myers 2009) |
LAB | GP3 | 7533 | Enr | Full | 22/22 | 100% | Tue 09-11 (w2-4,5-12, Myers 3016); Tue 11-13 (w2,4, Myers 2009); Tue 11-13 (w3,5-11, Myers 2009); Tue 11-13 (w12-13, Myers 2009) |
LAB | GP4 | 7534 | Enr | Stop | 21/22 | 95% | Wed 10-12 (w2,4, Myers 2009); Wed 10-12 (w3,5-11, Myers 2009); Wed 10-12 (w12-13, Myers 2009); Wed 14-16 (w2-4,5-12, Myers 3016) |
LAB | GP5 | 7535 | Enr | Open | 20/22 | 91% | Wed 11-13 (w2-4,5-12, Myers 3016); Wed 14-16 (w2,4, Myers 2009); Wed 14-16 (w3,5-11, Myers 2009); Wed 14-16 (w12-13, Myers 2009) |
LAB | GP6 | 10098 | Enr | Open | 16/22 | 73% | Tue 09-11 (w2-4,5-13, Myers 2009); Tue 16-18 (w2-4,5-12, Myers 3016) |
LEC | A | 7530 | Rel | Open | 123/127 | 97% | Mon 11 (w1, ElecEngG24); Mon 11 (w2-4,5-6,9, ElecEngG24); Mon 11 (w7, ElecEngG24); Thu 09-12 (Myers 2009); Thu 13 (w1, OMB149); Thu 13 (w2-4,5-12, OMB149); Thu 15 (w1-4,5-9, OMB149); Fri 15 (w1-3,5-9, ElecEngG24) |
TUT | 001 | 7536 | Rel | Full | 22/22 | 100% | Thu 12 (w2,7,10-11, BUS 105); Thu 12 (w5,9,12, BUS 105); Thu 12 (w6,8, BUS 105) |
TUT | 002 | 7537 | Rel | Stop | 22/22 | 100% | Thu 09 (w2,7,10-11, Quad G041); Thu 09 (w5,9,12, Quad G041); Thu 09 (w6,8, Quad G041) |
TUT | 003 | 7538 | Rel | Full | 22/22 | 100% | Thu 11 (w2,7,10-11, Quad G041); Thu 11 (w5,9,12, Quad G041); Thu 11 (w6,8, Quad G041) |
TUT | 004 | 7539 | Rel | Stop | 21/22 | 95% | Wed 09 (w2,7,10-11, Myers 2030); Wed 09 (w5,9,12, Myers 2030); Wed 09 (w6,8, Myers 2030) |
TUT | 005 | 7540 | Rel | Open | 20/22 | 91% | Thu 08 (w2,7,10-11, Quad G041); Thu 08 (w5,9,12, Quad G041); Thu 08 (w6,8, Quad G041) |
TUT | 006 | 10099 | Rel | Open | 16/22 | 73% | Tue 14 (w2,5-12, Myers 2030) |
OPTM3111 | Optometry 3A | ||||||
LAB | GP1 | 4749 | Enr | Stop | 22/22 | 100% | Fri 15-17 (w6, OMB G25); Fri 15-17 (w1-2, Myers 2009); Fri 15-17 (w3-4,7-13, Myers 2009); Fri 15-17 (w5, Myers 2009) |
LAB | GP2 | 4750 | Enr | Stop | 22/22 | 100% | Fri 09-11 (w6, OMB G25); Fri 09-11 (w1-2, Myers 2009); Fri 09-11 (w3-4,7-13, Myers 2009); Fri 09-11 (w5, Myers 2009) |
LAB | GP3 | 4751 | Enr | Open | 17/22 | 77% | Fri 11-13 (w6, OMB G25); Fri 11-13 (w1-2, Myers 2009); Fri 11-13 (w3-4,7-13, Myers 2009); Fri 11-13 (w5, Myers 2009) |
LAB | GP4 | 4752 | Enr | Stop | 20/22 | 91% | Thu 16-18 (w6, OMB G25); Thu 16-18 (w1-2, Myers 2009); Thu 16-18 (w3-4,7-13, Myers 2009); Thu 16-18 (w5, Myers 2009) |
LEC | A | 4748 | Rel | Open | 81/88 | 92% | Wed 11 (w1,4,5-12, Law Th G02); Wed 11 (w2-3, Law Th G02); Wed 12 (w1-2, Law Th G02); Thu 14-16 (w1,8-12, Law Th G23); Thu 14-16 (w2-4,5-6, Law Th G23); Thu 14-16 (w7, Law Th G23) |
TUT | 001 | 4753 | Rel | Stop | 22/22 | 100% | Fri 09-11 (w7, Law 101) |
TUT | 002 | 4754 | Rel | Stop | 22/22 | 100% | Fri 11-13 (w7, RedC 4037) |
TUT | 003 | 4755 | Rel | Open | 17/22 | 77% | Thu 16-18 (w7, RedC 4037) |
TUT | 004 | 4756 | Rel | Stop | 20/22 | 91% | Fri 15-17 (w7, RedC 4037) |
OPTM3131 | Ocular Disease 3A | ||||||
LAB | GP1 | 4759 | Enr | Stop | 22/22 | 100% | Thu 11-13 (w4,7,10, OPTM CL) |
LAB | GP2 | 4760 | Enr | Stop | 22/22 | 100% | Thu 16-18 (w4,7,10, OPTM CL) |
LAB | GP3 | 4761 | Enr | Open | 20/22 | 91% | Tue 15-17 (w4,7,10, OPTM CL) |
LAB | GP4 | 4762 | Enr | Stop | 22/22 | 100% | Wed 09-11 (w4,7,10, OPTM CL) |
LAB | GP5 | 4763 | Enr | Open | 20/22 | 91% | Wed 12-14 (w4,7,10, OPTM CL) |
LE1 | A | 4757 | Rel | Open | 106/108 | 98% | Tue 12-14 (CLB 4); Wed 14-16 (CivEng 101) |
LE2 | B | 4758 | Rel | Open | 106/108 | 98% | Mon 11 (CLB 4) |
OPTM4110 | Optometry 4A | ||||||
LAB | 501 | 4766 | Enr | Open | 21/22 | 95% | Mon 11-13 (Myers 2009) |
LAB | 502 | 4767 | Enr | Open | 10/22 | 45% | Wed 12-14 (Myers 2009) |
LAB | 503 | 4768 | Enr | Closed | 0/22 | 0% | Fri 13-15 |
LAB | 504 | 4769 | Enr | Open | 20/22 | 91% | Mon 14-16 (Myers 2009) |
LAB | 505 | 4770 | Enr | Open | 13/22 | 59% | Thu 14-16 (Myers 2009) |
LE2 | M09A | 4765 | Rel | Open | 64/92 | 70% | Mon 09-11 (w1, Myers Thtr); Mon 09-11 (w7, Myers Thtr) |
LEC | A | 4764 | Rel | Open | 64/92 | 70% | Mon 10 (w2-4,5-6,10-13, Myers Thtr); Mon 10 (w8-9, Myers Thtr) |
OPTM4131 | Clinical Optometry 4A | ||||||
LEC | M16A | 4777 | Enr | Open | 65/92 | 71% | Mon 16 (w2-4,5-13, Myers Thtr); Mon 17 (w10-13, Myers Thtr) |
OPTM4151 | Ocular Therapeutics 4A | ||||||
LAB | 501 | 4772 | Rel | Open | 17/20 | 85% | Tue 09-11 (w8-12, OPTM CL) |
LAB | 502 | 4773 | Rel | Open | 17/20 | 85% | Fri 09-11 (w8-12, OPTM CL) |
LAB | 503 | 4774 | Rel | Closed | 0/20 | 0% | Mon 11-13 (w8-12) |
LAB | 504 | 4775 | Rel | Open | 18/20 | 90% | Fri 11-13 (w8-12, OPTM CL) |
LAB | 505 | 4776 | Rel | Open | 17/20 | 85% | Tue 13-15 (w8-12, OPTM CL) |
LEC | T15A | 4771 | Enr | Open | 69/92 | 75% | Tue 15-17 (w2-4,5-13, CLB 3) |
OPTM4291 | Optom Med | ||||||
LEC | A | 3352 | Enr | Open | 75/92 | 82% | Mon 08 (w2-4,5-13, Myers Thtr); Tue 08 (w2-4,5-13, Myers Thtr); Fri 08 (w2-4,5-13, Myers Thtr) |
OPTM5111 | Clinical Optometry 5A | ||||||
LEC | 501 | 4778 | Enr | Open | 47/49 | 96% | Fri 13 (w2-4,5-13, Myers Thtr) |
OPTM5131 | Specialist Clinical Optom 5A | ||||||
LEC | A | 4779 | Enr | Open | 47/49 | 96% | Tue 15:30 (w2-4,5-13, Myers Thtr) |
OPTM5151 | Clinical Ocular Therap 5A | ||||||
CLN | 001 | 8949 | Enr | Full | 49/49 | 100% | |
OPTM5171 | Research Project 5A | ||||||
OTH | 001 | 8950 | Enr | Open | 46/49 | 94% | |
OPTM7006 | Eye Care Program Management | ||||||
LEC | 001 | 9462 | Enr | Open | 5/15 | 33% | |
OPTM7007 | Community Eye Health Project | ||||||
LEC | 001 | 9466 | Enr | Open | 0/15 | 0% | |
OPTM7103 | Behavioural Optometry 1 | ||||||
LEC | 001 | 9479 | Enr | Open | 14/30 | 47% | |
OPTM7104 | Adv. Contact Lens Studies 1 | ||||||
LEC | 001 | 9476 | Enr | Open* | 0/30 | 0% | |
OPTM7108 | Research Skills in Optometry | ||||||
LEC | 001 | 9464 | Enr | Open | 0/30 | 0% | |
OPTM7115 | Visual Neuroscience | ||||||
LEC | 001 | 9463 | Enr | Open | 11/30 | 37% | |
OPTM7213 | Ocular Therapy | ||||||
LEC | 001 | 9461 | Enr | Open | 44/50 | 88% | |
OPTM7302 | Evidence Based Optometry | ||||||
LEC | 001 | 9460 | Enr | Open | 16/30 | 53% | |
OPTM7308 | Research Project | ||||||
LEC | 001 | 9465 | Enr | Open | 4/30 | 13% | |
OPTM7511 | Advanced Ocular Disease 1 | ||||||
LEC | 001 | 9474 | Enr | Open | 11/15 | 73% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G Authorised by Deputy Vice Chancellor (Academic) & Registrar Privacy Statement Copyright & Disclaimer |